Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LIFE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

aTyr Pharma stock downgraded to Hold/Accumulate
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 21, 2024 Loss -3.47% PDF

The aTyr Pharma stock price fell by -2.50% on the last day (Thursday, 28th Mar 2024) from $2.00 to $1.95. During the last trading day the stock fluctuated 8.46% from a day low at $1.89 to a day high of $2.05. The price has fallen in 5 of the last 10 days but is still up by 20.37% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -473 thousand shares and in total, 725 thousand shares were bought and sold for approximately $1.41 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 29.62% during the next 3 months and, with a 90% probability hold a price between $2.20 and $2.67 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LIFE Signals & Forecast

The aTyr Pharma stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.97. On a fall, the stock will find some support from the long-term average at approximately $1.87. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 21, 2024, and so far it has fallen -3.47%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for aTyr Pharma stock

aTyr Pharma finds support from accumulated volume at $1.91 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.160 between high and low, or 8.46%. For the last week the stock has had daily average volatility of 6.43%.

Our recommended stop-loss: $1.86 (-4.56%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 5 days ago.)

Trading Expectations (LIFE) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect aTyr Pharma to open at $1.96, and during the day (based on 14 day Average True Range), to move between $1.81 and $2.09, which gives a possible trading interval of +/-$0.135 (+/-6.94%) up or down from last closing price. If aTyr Pharma takes out the full calculated possible swing range there will be an estimated 13.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.97 (1.03%) than the support at $1.91 (2.05%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is aTyr Pharma stock A Buy?

aTyr Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.162 Hold/Accumulate Downgraded

Predicted Opening Price for aTyr Pharma of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$1.96 ( 0.685%) $1.95

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LIFE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.12 8.89 %
R2 2.06 5.75 %
R1 2.02 3.82 %
Current price: 1.95
Support S1 1.90 -2.45 %
S2 1.86 -4.38 %
S3 1.80 -7.51 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.02 3.59 %
R2 2.00 2.56 %
R1 1.97 1.03 %
Current price 1.95
Support S1 1.91 -2.05%
S2 1.88 -3.59%
S3 1.66 -14.87%

FAQ

What is the symbol for aTyr Pharma Stock and on which exchange is it traded?
The symbol for aTyr Pharma is LIFE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell aTyr Pharma Stock?
aTyr Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy aTyr Pharma Stock?
aTyr Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy aTyr Pharma Stock.

What's the current price of aTyr Pharma Stock?
As of the end of day on the 2024-03-28, the price of an aTyr Pharma (LIFE) share was $1.95.

What is the 52-week high and low for aTyr Pharma Stock?
The 52-week high for aTyr Pharma Stock is $2.70 and the 52-week low is $1.08.

What is the market capitalization of aTyr Pharma Stock?
As of the 2024-03-28, the market capitalization of aTyr Pharma is 135.5M.

When is the next earnings date for aTyr Pharma?
The upcoming earnings date for aTyr Pharma is May 14, 2024.
Click to get the best stock tips daily for free!

About aTyr Pharma

aTyr Pharma aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and ... LIFE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT